3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes

被引：13

作者：

Blum, A ^{[1
]}

Simsolo, C

Hasin, Y

机构：

[1] Poria Med Ctr, Dept Internal Med A, IL-15208 Lower Galilee, Israel

[2] Poria Med Ctr, Dept Cardiol, IL-15208 Lower Galilee, Israel

来源：

ATHEROSCLEROSIS | 2004年 / 175卷 / 01期

关键词：

D O I：

10.1016/j.atherosclerosis.2003.12.024

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

页码：1 / 5

页数：5

共 17 条

[1]

Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[2]

Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients [J].

Holm, T ;

Andreassen, AK ;

Ueland, T ;

Kjekshus, J ;

Froland, SS ;

Kjekshus, E ;

Simonsen, S ;

Aukrust, P ;

Gullestad, L .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) :815-+

[3]

Jackson G, 2000, INT J CLIN PRACT, V54, P445

[4]

Statins as a newly recognized type of immunomodulator [J].

Kwak, B ;

Mulhaupt, F ;

Myit, S ;

Mach, F .

NATURE MEDICINE, 2000, 6 (12) :1399-1402

[5]

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors [J].

Laufs, U ;

La Fata, V ;

Plutzky, J ;

Liao, JK .

CIRCULATION, 1998, 97 (12) :1129-1135

[6]

Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasly (REGRESS trial) [J].

Mulder, HJGH ;

Bal, ET ;

Jukema, JW ;

Zwinderman, AH ;

Schalij, MJ ;

van Boven, AJ ;

Bruschke, AVG .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (07) :742-746

[7]

Impact of preexisting statin use on adhesion molecule expression in patients presenting with acute coronary syndromes [J].

Murphy, RT ;

Foley, JB ;

Mulvihill, N ;

Crean, P ;

Walsh, MJ .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (04) :446-+

[8]

Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials [J].

Pignone, M ;

Phillips, C ;

Mulrow, C .

BRITISH MEDICAL JOURNAL, 2000, 321 (7267) :983-986

[9]

The use of statins in acute coronary syndromes: the mechanisms behind the outcomes. [J].

Plana J.C. ;

Jones P.H. .

Current Atherosclerosis Reports, 2001, 3 (5) :355-364

[10]

Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease [J].

Schartl, M ;

Bocksch, W ;

Koschyk, DH ;

Voelker, W ;

Karsch, KR ;

Kreuzer, J ;

Hausmann, D ;

Beckmann, S ;

Gross, M .

CIRCULATION, 2001, 104 (04) :387-392

← 1 2 →